Showing 1 - 7 results of 7 for search 'Christer F. Aas', query time: 0.03s Refine Results
  1. 1
    Changes in substance use during outpatient treatment for substance use disorders: a prospective Norwegian cohort study from 2016 to 2020

    Changes in substance use during outpatient treatment for substance use disorders: a prospective Norwegian cohort study from 2016 to 2020 by Jørn Henrik Vold, Fatemeh Chalabianloo, Christer F. Aas, Else-Marie Løberg, Kjell Arne Johansson, Lars Thore Fadnes

    Published 2021-09-01
    Get full text
    Article
  2. 2
    Prevalence and correlates of suicide attempts in high-risk populations: a cross-sectional study among patients receiving opioid agonist therapy in Norway

    Prevalence and correlates of suicide attempts in high-risk populations: a cross-sectional study among patients receiving opioid agonist therapy in Norway by Jørn Henrik Vold, Else-Marie Løberg, Christer F. Aas, Jan Alexander Steier, Kjell Arne Johansson, Lars Thore Fadnes

    Published 2022-03-01
    Get full text
    Article
  3. 3
    Validation of a three-item Fatigue Severity Scale for patients with substance use disorder: a cohort study from Norway for the period 2016–2020

    Validation of a three-item Fatigue Severity Scale for patients with substance use disorder: a cohort study from Norway for the period 2016–2020 by Jørn Henrik Vold, Rolf Gjestad, Christer F. Aas, Eivind Meland, Kjell Arne Johansson, Lars Thore Fadnes, for the INTRO-HCV Study Group

    Published 2021-03-01
    Get full text
    Article
  4. 4
    Uptake and predictors of direct-acting antiviral treatment for hepatitis C among people receiving opioid agonist therapy in Sweden and Norway: a drug utilization study from 2014 to 2017

    Uptake and predictors of direct-acting antiviral treatment for hepatitis C among people receiving opioid agonist therapy in Sweden and Norway: a drug utilization study from 2014 to... by Christer F. Aas, Jørn Henrik Vold, Svetlana Skurtveit, Ingvild Odsbu, Fatemeh Chalabianloo, Aaron G. Lim, Kjell Arne Johansson, Lars Thore Fadnes

    Published 2020-06-01
    Get full text
    Article
  5. 5
    The efficacy of integrated hepatitis C virus treatment in relieving fatigue in people who inject drugs: a randomized controlled trial

    The efficacy of integrated hepatitis C virus treatment in relieving fatigue in people who inject drugs: a randomized controlled trial by Jørn Henrik Vold, Fatemeh Chalabianloo, Else-Marie Løberg, Christer F. Aas, Aaron G. Lim, Peter Vickerman, Kjell Arne Johansson, Lars Thore Fadnes

    Published 2023-04-01
    Get full text
    Article
  6. 6
    Effect of integrated hepatitis C virus treatment on psychological distress in people with substance use disorders

    Effect of integrated hepatitis C virus treatment on psychological distress in people with substance use disorders by Christer F. Aas, Jørn Henrik Vold, Fatemeh Chalabianloo, Else-Marie Løberg, Aaron G. Lim, Peter Vickerman, Kjell Arne Johansson, Lars Thore Fadnes

    Published 2024-01-01
    Get full text
    Article
  7. 7
    Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020

    Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020 by Jørn Henrik Vold, Rolf Gjestad, Christer F. Aas, Fatemeh Chalabianloo, Svetlana Skurtveit, Else-Marie Løberg, Kjell Arne Johansson, Lars Thore Fadnes, for the INTRO-HCV Study Group

    Published 2020-12-01
    Get full text
    Article

Search Tools: